SynthesisActa neurologica Belgica2024

Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain-Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review.

Mario B Prado et al.PubMed ↗Publisher ↗

No numbers read from the abstract.